Epizyme Inc (EPZM)
Epizyme Inc (EPZM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EPZM | AMGN | GILD | BIIB | CELG |
| Company | Epizyme Inc | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.4900 | 337.03 | 84.39 | 200.57 | 108.01 |
| High | 1.5000 | 338.70 | 84.65 | 204.18 | 108.59 |
| Low | 1.4700 | 334.61 | 83.57 | 200.11 | 107.27 |
| Last | 1.4700 | 337.22 | 84.18 | 202.26 | 108.24 |
| Change | -0.0200 | +4.30 | +0.29 | +4.67 | +0.11 |
| % Change | -1.34% | +1.29% | +0.35% | +2.36% | +0.10% |
| Volume | 22,276,000 | 772,388 | 4,687,914 | 591,236 | 191,230,496 |
| 20-Day Average Volume | 3,364,145 | 1,717,040 | 6,476,527 | 801,313 | 16,188,930 |
| Previous Close | 1.4900 | 332.92 | 83.89 | 197.59 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 1.4840 | 329.65 | 80.09 | 201.64 | 108.17 |
| 20-Day Raw Stochastic | 25.00% | 90.83% | 93.92% | 69.47% | 63.25% |
| 20-Day Relative Strength | 64.92% | 58.56% | 72.65% | 46.39% | 64.69% |
| Weighted Alpha | -67.50 | +27.73 | +19.03 | -21.15 | +46.30 |
| Today's Opinion | 8% Buy | 96% Buy | 88% Buy | 88% Sell | 100% Buy |
| Previous Opinion | 24% Buy | 88% Buy | 88% Buy | 100% Sell | 100% Buy |
| Last Month's Opinion | 8% Buy | 88% Buy | 56% Buy | 88% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.68% since 08/04/22 | +2.15% since 09/12/24 | +1.38% since 09/12/24 | +2.24% since 09/12/24 | -1.97% since 11/13/19 |
| Low | 1.4700 on 08/11/22 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 192.25 on 09/13/24 | 107.27 on 11/20/19 |
| High | 1.5300 on 08/08/22 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 204.18 on 09/19/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | unch since 07/11/22 | +2.80% since 08/19/24 | +13.24% since 08/19/24 | -1.81% since 08/19/24 | +5.14% since 10/18/19 |
| Low | 1.4500 on 08/04/22 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 192.25 on 09/13/24 | 102.40 on 10/21/19 |
| High | 1.5300 on 08/08/22 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 207.59 on 08/21/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | +214.30% since 05/11/22 | +10.19% since 06/18/24 | +33.51% since 06/18/24 | -9.53% since 06/18/24 | +13.63% since 08/20/19 |
| Low | 0.4110 on 06/01/22 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 192.25 on 09/13/24 | 93.41 on 08/23/19 |
| High | 1.5800 on 06/27/22 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 238.00 on 07/12/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | -9.82% since 02/11/22 | +24.08% since 03/19/24 | +14.85% since 03/19/24 | -7.46% since 03/19/24 | +14.14% since 05/20/19 |
| Low | 0.4110 on 06/01/22 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 1.7650 on 03/03/22 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 238.00 on 07/12/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 247,444 | 178,589,936 | 104,514,608 | 28,768,510 | 77,035,920 |
| Shares Outstanding, K | 168,329 | 536,435 | 1,245,853 | 145,597 | 711,714 |
| Annual Sales | 37,430,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -251,120,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 8,700,000 | 8,388,000,000 | 6,954,000,000 | 2,464,900,000 | 4,520,000,000 |
| Last Quarter Net Income | -55,510,000 | 746,000,000 | 1,614,000,000 | 583,600,000 | 1,691,000,000 |
| 60-Month Beta | -0.41 | 0.61 | 0.18 | -0.06 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 08/09/22 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 5.28 on 08/01/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 08/08/22 | 10/29/24 | 11/05/24 | 08/01/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.89 | 17.67 | 12.19 | 10.99 |